Aranesp and Paget-schroetter syndrome - a phase IV clinical study of FDA data

Summary:

Paget-schroetter syndrome is reported only by a few people who take Aranesp.

The phase IV clinical study analyzes which people take Aranesp and have Paget-schroetter syndrome. It is created by eHealthMe based on reports of 50,679 people who have side effects while taking Aranesp from the FDA, and is updated regularly.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.



On Feb, 02, 2023

50,679 people reported to have side effects when taking Aranesp.
Among them, 3 people (0.01%) have Paget-schroetter syndrome.


What is Aranesp?

Aranesp has active ingredients of darbepoetin alfa. It is often used in anemia. eHealthMe is studying from 50,791 Aranesp users for its effectiveness, alternative drugs and more.

What is Paget-schroetter syndrome?

Paget-schroetter syndrome (thrombosis of the upper extremity) is found to be associated with 44 drugs and 37 conditions by eHealthMe.

Number of Aranesp and Paget-schroetter syndrome reports submitted per year:

Could Aranesp cause Paget-schroetter syndrome?

Time on Aranesp when people have Paget-schroetter syndrome *:

  • < 1 month: 0.0 %
  • 1 - 6 months: 100 %
  • 6 - 12 months: 0.0 %
  • 1 - 2 years: 0.0 %
  • 2 - 5 years: 0.0 %
  • 5 - 10 years: 0.0 %
  • 10+ years: 0.0 %

Gender of people who have Paget-schroetter syndrome when taking Aranesp *:

  • female: 100 %
  • male: 0.0 %

Age of people who have Paget-schroetter syndrome when taking Aranesp *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 0.0 %
  • 50-59: 0.0 %
  • 60+: 100 %

Common drugs people take besides Aranesp *:

  1. Taxotere: 2 people, 66.67%
  2. Cyclophosphamide: 2 people, 66.67%
  3. Adriamycin Pfs: 2 people, 66.67%
  4. Doxorubicin Hydrochloride: 1 person, 33.33%

Common side effects people have besides Paget-schroetter syndrome *:

  1. Axillary Vein Thrombosis (formation of a blood clot in axillary vein): 3 people, 100.00%
  2. Swelling: 2 people, 66.67%
  3. Catheter Site Related Reaction: 2 people, 66.67%
  4. Thyroid Diseases: 1 person, 33.33%
  5. Parathyroid Disorder: 1 person, 33.33%

Common conditions people have *:

  1. Anaemia Of Malignant Disease: 3 people, 100.00%

* Approximation only. Some reports may have incomplete information.

Do you take Aranesp and have Paget-schroetter syndrome?

Check whether Paget-schroetter syndrome is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.



Related studies

How severe was Paget-schroetter syndrome and when was it recovered:

Expand to all the drugs that have ingredients of darbepoetin alfa:

Alternative drugs to, pros and cons of Aranesp:

Common Aranesp side effects:

Browse all side effects of Aranesp:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Paget-schroetter syndrome treatments and more:

COVID vaccines that are related to Paget-schroetter syndrome:

All the drugs that are associated with Paget-schroetter syndrome:

All the conditions that are associated with Paget-schroetter syndrome:

How the study uses the data?

The study uses data from the FDA. It is based on darbepoetin alfa (the active ingredients of Aranesp) and Aranesp (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: